You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MM-Multiple Myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Zwolle (e-coach multipel myeloma (MM))

Recruiting
  • Multiple Myeloma
  • e-coach multipel myeloma (MM)
  • Zwolle, Overijssel, Netherlands
    Isala Klinieken
Jul 26, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Multiple Myeloma Cells From miRNAs Released From B Cells, and

Recruiting
  • Multiple Myeloma
    • Aviano, Pordenone, Italy
      Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
    Nov 23, 2023

    Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

    Not yet recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • GC012F
    • (no location specified)
    Apr 28, 2023

    Real-World Mapping Antithrombotic Regimens in MM Patients on

    Not yet recruiting
    • Multiple Myeloma
    • Diagnosis
      • (no location specified)
      Aug 31, 2023

      Multiple Myeloma Trial in Montréal (Elranatamab)

      Not yet recruiting
      • Multiple Myeloma
      • Montréal, Quebec, Canada
        McGill University Health Centre
      Sep 21, 2023

      Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

      Not yet recruiting
      • Multiple Myeloma in Relapse
      • Multiple Myeloma, Refractory
      • Anti-GPRC5D CAR-T Cells Injection
      • (no location specified)
      Feb 18, 2023

      Learn How Triple Class Refractory Multiple Myeloma Are Treated

      Not yet recruiting
      • Relapse Multiple Myeloma
      • Refractory Multiple Myeloma
        • (no location specified)
        Feb 15, 2023

        Biomarker for Infection Risk in CLL and MM

        Not yet recruiting
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Screening
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        May 3, 2023

        Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

        Not yet recruiting
        • Multiple Myeloma
        • Budesonide EC
        • Placebo
        • Salt Lake City, Utah
          Huntsman Cancer Institute at the University of Utah
        Jan 9, 2023

        Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

        Recruiting
        • Multiple Myeloma in Relapse
        • Multiple Myeloma, Refractory
        • Anti-GPRC5D CAR-T cells infusion
        • Kunming, Yunnan, China
        • +1 more
        Feb 21, 2023

        Medicine Called Elranatamab in People With Relapsed Refractory

        Not yet recruiting
        • Multiple Myeloma
        • (no location specified)
        Jun 30, 2023

        Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

        Recruiting
        • Multiple Myeloma in Remission
        • MM-specific universal CAR T cells
        • Shenzhen, Guangdong, China
        • +1 more
        Aug 23, 2023

        Real-world Usage of HyQvia in Multiple Myeloma Secondary

        Not yet recruiting
        • Multiple Myeloma
        • Secondary Immunodeficiency (SID)
        • No Intervention
        • (no location specified)
        May 19, 2023

        Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

        Completed
        • Multiple Myeloma
        • Saint Louis, Missouri
          Washington University School of Medicine
        Nov 22, 2022

        Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

        Not yet recruiting
        • Multiple Myeloma
        • Augusta, Georgia
          Georgia Cancer Center at Augusta University
        Apr 26, 2023

        Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

        Recruiting
        • Multiple Myeloma
        • Palliative Care
        • +2 more
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        Jan 17, 2023

        Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

        Not yet recruiting
        • Relapsed or Refractory Multiple Myeloma
        • (no location specified)
        Jun 22, 2023

        Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

        Not yet recruiting
        • Multiple Myeloma
        • (no location specified)
        Nov 28, 2023

        Multiple Myeloma, Complication Trial in Lyon (Interpretation of the results from the detection visit, Explaining detection

        Not yet recruiting
        • Multiple Myeloma
        • Complication
        • Interpretation of the results from the detection visit
        • +3 more
        • Lyon, France
          Centre Léon Bérard
        Jul 7, 2023

        Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

        Recruiting
        • Multiple Myeloma
        • Plasma Cell Leukemia
        • Human BCMA targeted CAR-NK cells injection
        • Shanghai, Shanghai, China
          Shanghai Changzheng Hospital
        Sep 13, 2023

        Two Biologically and Clinically Distinct Entities: Progressive

        Recruiting
        • Multiple Myeloma
        • +2 more
          • Miami, Florida
            University of Miami Hospitals
          Jun 7, 2022

          Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

          Recruiting
          • Multiple Myeloma
          • Ann Arbor, Michigan
          • +3 more
          Jan 19, 2023

          Immunophenotyping of Plasma Cells and Immune Effector Cells in

          Not yet recruiting
          • Multiple Myeloma
          • Biological sampling
          • (no location specified)
          Jun 17, 2022

          Serum NGAL IN Patients With Multiple Myeloma

          Not yet recruiting
          • Multiple Myeloma(MM)
          • SERUM NGAL
          • (no location specified)
          Jun 26, 2022